Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,591.70INR
14 Dec 2018
Change (% chg)

Rs-5.15 (-0.20%)
Prev Close
Rs2,596.85
Open
Rs2,595.00
Day's High
Rs2,609.60
Day's Low
Rs2,568.00
Volume
586,360
Avg. Vol
952,583
52-wk High
Rs2,749.95
52-wk Low
Rs1,887.00

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Launches Omeprazole Delayed-Release Tablets In U.S.
Tuesday, 11 Dec 2018 12:06am EST 

Dec 11 (Reuters) - Dr.Reddy's Laboratories Ltd ::LAUNCHES OMEPRAZOLE DELAYED-RELEASE TABLETS, 20 MG IN U.S. MARKET.  Full Article

Indivior Posts Rise in Qtrly Earnings, Affirms FY Guidance
Thursday, 1 Nov 2018 07:01am EDT 

Nov 1 (Reuters) - Indivior Plc ::3RD QUARTER RESULTS.ON TRACK TO ACHIEVE FY 2018 REVISED GUIDANCE OF NET REVENUE IN RANGE OF $990-$1,020 MLN.QTRLY REVENUE $245 MILLION VERSUS $275 MILLION REPORTED LAST YEAR.ON TRACK TO ACHIEVE FY 2018 REVISED GUIDANCE OF ADJUSTED NET INCOME IN RANGE OF $230-$255 MLN.INDIVIOR PLC QTRLY NET INCOME $89 MILLION VERSUS $50 MILLION REPORTED LAST YEAR.INDIVIOR PLC QTRLY ADJUSTED NET INCOME $58 MILLION VERSUS $47 MILLION REPORTED LAST YEAR.SUBOXONE FILM MARKET SHARE AVERAGED 54 PCT YTD 2018 (YTD 2017: 58 PCT), EXITING Q3 2018 AT 52 PCT.CONFIRMS THAT FY 2018 SUBLOCADE NET REVENUES ARE EXPECTED IN RANGE OF $8 MLN TO $10 MLN.MAKING GOOD PROGRESS AGAINST ITS PREVIOUSLY-ANNOUNCED COST SAVINGS INITIATIVE THAT TARGETS AT LEAST $55M IN PRE-TAX SAVINGS IN 2018.COST SAVINGS EXPECTED TO GENERATE ANNUAL PRE-TAX SAVINGS BETWEEN $80 MLN TO $100 MLN IN FY 2019.EXPECTS ADVERSE IMPACT OF DR. REDDY'S LABORATORIES' "AT-RISK" LAUNCH ON FY 2018 NET REVENUE TO BE BETWEEN $12 MLN AND $18 MLN.COST SAVINGS TO HELP MITIGATE AGAINST POTENTIAL IMPACTS TO CO'S PROFITABILITY FROM POTENTIAL GENERIC FILM ENTRANT IN U.S..  Full Article

Dr.Reddy's Laboratories Says Unit Filed Lawsuit Against Perrigo UK Finco, Perrigo Israel Pharma, Taro Pharmaceuticals
Friday, 25 May 2018 08:35am EDT 

May 25 (Reuters) - Dr.Reddy's Laboratories Ltd ::UNIT PROMIUS PHARMA FILED LAWSUIT FOR PATENT INFRINGEMENT IN U.S. COURT.FILED LAWSUIT AGAINST PERRIGO UK FINCO, PERRIGO ISRAEL PHARMACEUTICALS, AND TARO PHARMACEUTICALS.LAWSUIT FILED IN RESPONSE TO NOTICE LETTERS RECEIVED FOR TOPICAL SPRAY SERNIVO PRODUCT.UNIT ANTICIPATES LAWSUIT WILL TRIGGER A 30 MONTH STAY OF FDA APPROVAL OF PERRIGO'S AND TARO'S ANDAS.  Full Article

Dr.Reddy's Laboratories Gets EIR From US FDA For API Cuernavaca Plant In Mexico
Tuesday, 10 Apr 2018 02:06am EDT 

April 10 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GETS EIR FROM US FDA FOR API CUERNAVACA PLANT IN MEXICO.  Full Article

Dr.Reddy's Labs' U.S. Unit Announces ANDA Filing For Migraine Candidate
Monday, 2 Apr 2018 05:43am EDT 

April 2 (Reuters) - Dr.Reddy's Laboratories Ltd ::CO, U.S. UNIT PROMIUS PHARMA ANNOUNCE FILING OF AN NDA FOR MIGRAINE CANDIDATE.UPON APPROVAL, PRODUCT WILL BE COMMERCIALISED BY PROMIUS PHARMA.  Full Article

Dr.Reddy's Laboratories Appoints Erez Israeli As Chief Operating Officer
Thursday, 29 Mar 2018 01:03am EDT 

March 29 (Reuters) - Dr.Reddy's Laboratories Ltd ::CHIEF OPERATING OFFICER ABHIJIT MUKHERJEE TO RETIRE ON MARCH 31.APPOINTS EREZ ISRAELI AS CHIEF OPERATING OFFICER.  Full Article

Dr.Reddy's Labs Gets Form 483 With 4 Observations For API Hyderabad Plant Audit
Friday, 16 Mar 2018 05:36am EDT 

March 16 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS AUDIT OF API HYDERABAD PLANT IN TELENGANA BY U.S. FDA COMPLETED ON MARCH 16.SAYS CO BEEN ISSUED ONE FORM 483 WITH 4 OBSERVATIONS.  Full Article

Dr.Reddy's Laboratories Launches Levocetirizine Dihydrochloride Tablets USP, 5 Mg In U.S.
Friday, 16 Mar 2018 01:58am EDT 

March 16 (Reuters) - Dr.Reddy's Laboratories Ltd ::ANNOUNCES LAUNCH OF LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP, 5 MG IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories Gets 5 Observations From U.S FDA For API Unit At Hyderabad ‍​
Friday, 9 Mar 2018 04:53am EST 

March 9 (Reuters) - Dr.Reddy's Laboratories Ltd ::U.S FDA ISSUES FORM 483 WITH 5 OBSERVATIONS FOR API UNIT AT HYDERABAD ‍​.  Full Article

Dr.Reddy's Laboratories Says Amended Complaint w.r.t U.S. Class Action Lawsuit Filed
Monday, 19 Feb 2018 01:33am EST 

Feb 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::W.R.T U.S. CLASS ACTION LAWSUIT, AMENDED COMPLAINT FILED BY PLAINTIFF WHERE CHAIRMAN, COO AND U.S. UNIT ADDED AS DEFENDANTS.  Full Article

UPDATE 2-Cost cuts help drugmaker Indivior as it battles cheap rival

* Shares give back early gains to trade lower (Adds details on the company's drugs, background, comments)